Walleye Trading LLC Novo Cure LTD Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $47,859 - $67,854	-4,300 Reduced 47.78%	4,700 $70,000
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $145,350 - $381,150	9,000 New	9,000 $145,000
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $665,992 - $1.4 Million	11,800 Added 161.64%	19,100 $1.15 Million
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $441,462 - $589,053	-6,900 Reduced 48.59%	7,300 $535,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $6,798 - $8,957	100 Added 0.71%	14,200 $1.08 Million
Q2 2022 Aug 08, 2022	SELL	$56.6 - $89.9 $147,160 - $233,740	-2,600 Reduced 15.57%	14,100 $980,000
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $505,260 - $709,968	8,400 Added 101.2%	16,700 $1.38 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $52,556 - $85,393	700 Added 9.21%	8,300 $623,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $58,085 - $97,275	-500 Reduced 6.17%	7,600 $883,000
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $1.03 Million - $1.78 Million	7,900 Added 3950.0%	8,100 $1.8 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $3.97 Million - $6.09 Million	-32,000 Reduced 99.38%	200 $26,000
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $3.39 Million - $5.26 Million	-30,200 Reduced 48.4%	32,200 $5.57 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $3.47 Million - $6.65 Million	59,700 Added 2211.11%	62,400 $6.95 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $223,080 - $290,199	-3,900 Reduced 59.09%	2,700 $160,000
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $11,410 - $19,150	-200 Reduced 2.94%	6,600 $444,000
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $3.69 Million - $5.07 Million	-54,000 Reduced 88.82%	6,800 $573,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $2.53 Million - $4 Million	40,900 Added 205.53%	60,800 $4.55 Million
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $3.21 Million - $4.81 Million	-76,100 Reduced 79.27%	19,900 $1.26 Million
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $2.59 Million - $4.55 Million	81,100 Added 544.3%	96,000 $4.62 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $226,888 - $415,777	-7,900 Reduced 34.65%	14,900 $499,000
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $464,000 - $759,800	14,500 Added 174.7%	22,800 $1.2 Million
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $10.2 Million - $16.5 Million	-514,100 Reduced 98.41%	8,300 $260,000
Q1 2018 May 15, 2018	BUY	$19.3 - $23.65 $9.66 Million - $11.8 Million	500,700 Added 2307.37%	522,400 $11.4 Million
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $353,710 - $475,229	21,700	21,700 $438,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account